Radioligand Therapy Prolongs Survival in Metastatic Cancer
Researchers have made a significant breakthrough in treating metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The Phase III COMPETE clinical trial has produced groundbreaking…